Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 14/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.57 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.57 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.57 |
| ▸ | C1S | P09871 | 1/20 | 0.54 |
| ▸ | GHSR | Q92847 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13508799 | 0.88 | KCNH2 (0.59) | NR1I2CYP11B1CYP11B2GHSR | |
| SCHEMBL22533660 | 0.84 | GHSR (0.52) | NR1I2CYP11B1CYP11B2C1SGHSR | |
| SCHEMBL8874396 | 0.81 | ALDH1A1 (0.59) | NR1I2GHSRKMT2A | |
| SCHEMBL15345067 | 0.79 | CYP11B1 (0.68) | NR1I2TNFCYP11B1CYP11B2KMT2A | |
| SCHEMBL3602016 | 0.78 | DRD2 (0.55) | KMT2A | |
| SCHEMBL3641606 | 0.77 | DRD2 (0.41) | NR1I2C1S | |
| SCHEMBL9680188 | 0.77 | ALDH1A1 (0.45) | NR1I2C1SGHSRKMT2A | |
| SCHEMBL4748504 | 0.76 | PKM (0.77) | NR1I2TNFCYP11B1CYP11B2KMT2A | |
| SCHEMBL3761479 | 0.76 | CYP11B1 (0.66) | NR1I2TNFCYP11B1CYP11B2 | |
| SCHEMBL15206007 | 0.76 | CYP11B1 (0.66) | NR1I2TNFCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100028299-A1 | Methods and compositions of treating a flaviviridae family viral infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2010-02-04 | — | — | US | disclosed |
| US-20100028299-A1 | Methods and compositions of treating a flaviviridae family viral infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2010-02-04 | — | — | US | disclosed |
| EP-1211555-B1 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJIFILM CORP (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-6875562-B2 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JP) | 2005-04-05 | — | — | US | disclosed |
| US-20030215760-A1 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. | 2003-11-20 | — | — | US | disclosed |
| US-6537742-B2 | Photosensitivity; light absorption strength; latent imaging | FUJI PHOTO FILM CO., LTD. (JP) | 2003-03-25 | — | — | US | disclosed |
| EP-0838719-B1 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJI PHOTO FILM CO LTD (JP) | 2003-02-12 | — | — | EP | disclosed |
| US-20020150848-A1 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. | 2002-10-17 | — | — | US | disclosed |
| EP-1211555-A2 | Silver halide photographic emulsion and silver halide photographic material containing said silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JP) | 2002-06-05 | — | — | EP | disclosed |
| US-6387610-B1 | SILVER HALIDE EMULSION SPECTRA SENSITIZED | FUJI PHOTO FILM CO., LTD. (JP) | 2002-05-14 | — | — | US | disclosed |
| US-5449596-A | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1995-09-12 | — | — | US | disclosed |
| US-5387483-A | Developer containing silver halide solvent and hydroquinone; has pH up to 11.8 | FUJI PHOTO FILM CO., LTD. (JP) | 1995-02-07 | — | — | US | disclosed |
| EP-0618492-A2 | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1994-10-05 | — | — | EP | disclosed |
| EP-0608777-A1 | Processing of lithographic printing material | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0601600-A2 | Processing of lithographic printing material and developer used therein | FUJI PHOTO FILM CO., LTD. (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0598241-A1 | Lithographic printing material | FUJI PHOTO FILM CO., LTD. (JP) | 1994-05-25 | — | — | EP | disclosed |
| US-5260183-A | Cyanine dye, thiocyanate, triazolopyrimidine spectral sensitizer | FUJI PHOTO FILM CO., LTD. (JP) | 1993-11-09 | — | — | US | disclosed |
| US-5035984-A | Computer output images, nucleating agent | FUJI PHOTO FILM CO., LTD. (JP) | 1991-07-30 | — | — | US | disclosed |
| US-5015561-A | Method for forming a direct positive image | FUJI PHOTO FILM CO., LTD. (JP) | 1991-05-14 | — | — | US | disclosed |
| EP-0331185-A2 | Silver halide photographic element for forming direct positive images and a method for forming said images | FUJI PHOTO FILM CO., LTD. (JP) | 1989-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028299-A1 | Methods and compositions of treating a flaviviridae family viral infection | EIF2AK2, NSUN3, NSUN2 | NR1I2 2181/4885TNF 2956/4885CYP11B1 3424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.